01
Customer & Voice of Customer
Uncover what clinicians, decision-makers and buyers actually value, object to and need before a major commercial decision.
For MedTech · Medical Device · IVD Founders
You built the product.
Now, how do you make the market buy it?
The hardest part of MedTech growth is often not the technology. It is knowing what the market is really telling you — and what to do next when customers, clinicians, procurement teams, partners or competitors create uncertainty.
KawaHive helps MedTech founders turn market reality into clearer commercial decisions across Asia Pacific.
Start a ConversationThe questions that matter
1
Why aren't they buying?Find the real objection, priority or missing value.
2
Why isn't the market responding?Separate product, positioning, customer and market-fit issues.
3
Where should you compete?Test market, segment, pricing and competitive realities.
4
What should you change?Turn evidence into a clearer commercial decision.
First-hand MedTech experience across clinical, commercial, customer & market environments · Asia Pacific
The problem
Clearance is not commercialisation.
A strong product, funding and regulatory approval are necessary. They do not automatically create adoption, traction or revenue.
We work on the commercial side — understanding customers, validating demand, sharpening positioning, assessing market opportunities and equipping teams to execute. We are not a regulatory consultancy.
Clinicians
Decision-makers
Procurement
Commercial teams
Six commercial lenses
Where we create commercial clarity.
Six connected areas help founders diagnose what is getting in the way — and make a better commercial decision before spending more time or money.
02
Product & Value Story
Translate clinical and technical strengths into a value proposition that makes sense to the people who influence the purchase.
03
Commercial & Partner Readiness
Assess whether the commercial model and partner strategy are strong enough to take the product forward.
04
Market & Competitive Reality
Pressure-test where the product can compete — including segments, competitors, pricing dynamics and tender realities.
05
Market Entry & Opportunity
Identify practical opportunities, the right starting point and the commercial conditions needed to introduce or expand a product.
06
Commercial Enablement
Build sales and channel capability through commercial training, customer conversations, workshops, demos and practical tools.
You are not buying more activity. You are getting a clearer view of what is really happening in the market — and what to do about it.
Selected market experience
What this looks like in the real world.
Examples below are based on market and distributor work undertaken in Asia. They are shared without confidential company or customer information.
Sri Lanka · Distributor strategy
When the problem wasn't sales.
A product was repeatedly losing head-to-head evaluations against stronger higher-end alternatives. The issue was not simply sales execution — the product-market fit and positioning were difficult in that competitive environment.
Decision: reassess product-market fit, sharpen positioning and focus commercial effort where the opportunity was stronger.
South Asia · New clinical opportunity
From an overlooked opportunity to a tender specification.
A new clinical application required sustained market education before a commercial opportunity emerged. After building interest with clinicians, the opportunity progressed toward institutional tender specifications.
Decision: create a practical route from market education to a specific institutional opportunity.
Southeast Asia · Market opportunity
When the obvious market was not the best opening.
With one clinical segment heavily contested by low-cost brands, attention shifted toward a different clinical opportunity. The work included supporting tender specifications and exploring a potential first breakthrough opportunity.
Decision: focus commercial effort where the competitive conditions created a more realistic opening.
How we work
Listen. Diagnose. Challenge. Activate.
01
Listen
Understand the product, the commercial question and what customers or partners are saying.
02
Diagnose
Separate symptoms from the underlying issue — product, positioning, channel, market or execution.
03
Challenge
Pressure-test assumptions against customer, competitor, tender and distributor realities.
04
Activate
Turn the findings into a practical decision, message, partner plan, market action or enablement tool.
Who we help
For founders trying to turn a good product into a real market opportunity.
MedTech & medical device founders
Founders entering, expanding or reassessing markets in Asia — especially when traction is slower, harder or less predictable than expected.
Founder-led commercial teams
Teams that need an independent view on customers, positioning, market opportunities, competitive realities or commercial execution.
Growth-stage MedTech teams
Growth-stage teams that need to validate an opportunity, reassess market traction or make a more confident commercial move.
Why KawaHive
Closer to what actually happens between the product and the purchase.
Our perspective is built at the intersection of clinical understanding, customer conversations, market realities and commercial execution across Asia.
Built from the field
Experience spans clinical education, product and market work, channel support and customer-facing problem solving — not just strategy documents.
Independent perspective
We are not selling a manufacturer portfolio, a regulatory service or a marketing campaign. The question is what makes commercial sense for the situation.
Asia is part of the lens
Tender dynamics, competitive pressure, pricing, local buying behaviour and partner capability can materially change the route to market.
Evidence before opinion
We start with the customer, channel and market signals available — then challenge assumptions and translate them into a decision.
We don't claim to know the market from a distance. We get closer to the people, decisions and commercial realities that determine whether a product moves.
A practical partner for founder-led teams
Senior thinking without the agency layers.
KawaHive is designed to give founders senior commercial, clinical and market perspective on a specific problem — bringing in specialist expertise only where the work requires it.
Right expertise for the question
Not every challenge needs the same specialist. The approach can draw on clinical, commercial, channel or market expertise as required.
Confidential by design
Client situations and market conversations are handled with discretion. Public examples are anonymised and shared only at an appropriate level.
FAQ
Direct answers.
Are you a regulatory consultancy?
No. We do not handle submissions or compliance. Our work begins on the commercial side: customers, positioning, channels, markets and enablement.
How are you different from a marketing agency?
The starting point is the commercial problem, not the campaign. We look at the product, customer, channel and market together before deciding what communication or action is actually needed.
Do you replace an internal Clinical Applications team?
No. Clinical Applications teams are critical for product and clinical support. KawaHive looks more broadly at the commercial question: what is stopping adoption, customer traction or market growth?
Do you work with commercial partners?
Yes. Partner capability, market fit, commercial confidence and customer-facing execution can be important parts of a MedTech market-entry or growth situation.
Do you work with growth-stage teams?
Yes. The work can help growth-stage teams validate market assumptions, understand traction barriers and make clearer commercial decisions.
When should we engage?
When the product is ready — or already in market — but there is uncertainty around customer demand, positioning, market choice, competitive pressure, partner strategy or the next commercial move.
Start with a 30-minute conversation.
A focused conversation to understand the commercial challenge, see whether there is a fit, and decide whether a deeper discussion is worthwhile. No pitch deck. No obligation.